The FDA cleared Access MeMed BV, a host-response blood test that helps distinguish bacterial from viral infections in adults and children in as little as 15 minutes.
|Articles|April 30, 2021
COVID-19 Updates: US Vaccinations and Global Cases and Deaths as of April 30, 2021
Author(s)Sydney Jennings
Data from the Johns Hopkins COVID-19 interactive map and the CDC on COVID-19 cases, mortalities, vaccinations, and more.
Advertisement
How many people in the US have been vaccinated against COVID-19?
According to the US
• 43.6% of total US population have received at least 1 dose
• 30.5% of total US population are fully vaccinated
• 30.5% of total US population are fully vaccinated
The 5 states with the highest percentage of population fully vaccinated are:
1. Maine: 39.3%
2. Connecticut: 38.5%
3. Vermont: 37.3%
4. New Mexico: 37.2%
5. South Dakota: 36.7%
2. Connecticut: 38.5%
3. Vermont: 37.3%
4. New Mexico: 37.2%
5. South Dakota: 36.7%
How many cases of COVID-19 have been confirmed in the US?
According to the
• 32 306 988 confirmed cases
• 575 434 deaths
• 575 434 deaths
The 5 states with the highest total confirmed cases are:
1. California: 3 740 456
2. Texas: 2 890 638
3. Florida: 2 228 212
4. New York: 2 044 345
5. Illinois: 1 331 747
2. Texas: 2 890 638
3. Florida: 2 228 212
4. New York: 2 044 345
5. Illinois: 1 331 747
Deaths: California has the most deaths due to COVID-19 with 61 738 reported fatalities, followed by New York with 52 209, and Texas with 50 166.
How many cases of COVID-19 have been confirmed globally?
Globally, there have been 150 751 023 confirmed cases, 3 170 271 deaths, and 87 813 067 recoveries.
Advertisement
Related to this article
Catch up on the 9 FDA drug approvals most relevant to primary care, including new options for HIV-1 infection, narcolepsy, diabetes, pain management, and more.
Evolocumab was associated with a 20% lower risk of fatal or nonfatal myocardial infarction than ezetimibe among more than 544 000 adults with ASCVD.
Greater Mediterranean diet adherence was associated with lower odds of adult acne, particularly among women, in a UK Biobank study of dietary patterns.
Abbott's investigational device achieved 96.3% complete left atrial appendage closure by echocardiography, with a 1.8% ischemic stroke rate at 1 year.
October FDA news included updates on long-acting olanzapine, multi-cancer blood testing, stroke rehabilitation, and heart failure monitoring.
Christoph Correll, MD, discusses the new once-monthly olanzapine injection for schizophrenia, including clinical efficacy, metabolic risks, and patient selection.
Cheryl Cox Kinney, MD, explains when night sweats warrant further evaluation, including red flags, persistent symptoms, and potential nonmenopausal causes.
Advertisement
Advertisement